{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:44:37Z","timestamp":1761489877849},"reference-count":60,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","trasci.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion and Apheresis Science"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.transci.2016.01.008","type":"journal-article","created":{"date-parts":[[2016,1,11]],"date-time":"2016-01-11T17:13:46Z","timestamp":1452532426000},"page":"24-29","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["ABO blood group mismatched hematopoietic stem cell transplantation"],"prefix":"10.1016","volume":"54","author":[{"given":"Sibel Akp\u0131nar","family":"Tekg\u00fcnd\u00fcz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nam\u0131k","family":"\u00d6zbek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.transci.2016.01.008_bib0010","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/bmt.2009.141","article-title":"Europian Group for Blood and Marrow Transplantation. Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009","volume":"45","author":"Ljungman","year":"2010","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"10.1016\/j.transci.2016.01.008_bib0015","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.transci.2010.03.008","article-title":"European survey on clinical use of cord blood for hematopoietic and non-hematopoietic indications","volume":"42","author":"Gratwohl","year":"2010","journal-title":"Transfus Apher Sci"},{"issue":"4","key":"10.1016\/j.transci.2016.01.008_bib0020","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/bmt.2014.312","article-title":"Hematopoietic SCT in Europe 2013: recent trends in the use of alternative donors showing more haploidentical donors but fewer cord blood transplants","volume":"50","author":"Passweg","year":"2015","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"10.1016\/j.transci.2016.01.008_bib0025","first-page":"4609","article-title":"Immunohematologic problems arising from ABO incompatible bone marrow transplantation","volume":"19","author":"Sniecinski","year":"1987","journal-title":"Transplant Proc"},{"issue":"3","key":"10.1016\/j.transci.2016.01.008_bib0030","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1182\/blood.V96.3.1150","article-title":"Graft-versus-host disease and donor\u2013directed hemagglutinin titers after ABO-mismatched related and unrelated marrow allografts: evidence for a graft-versus-plasma cell effect","volume":"96","author":"Mielcarek","year":"2000","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.transci.2016.01.008_bib0035","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.3324\/haematol.12933","article-title":"Impact of ABO\u2013blood group incompatibility on the outcome of recipients of bone marrow transplants from unrelated donors in the Japan Marrow Donor Program","volume":"93","author":"Kimura","year":"2008","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.transci.2016.01.008_bib0040","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/00007890-197810000-00006","article-title":"ABO-incompatible marrow transplants","volume":"26","author":"Buckner","year":"1978","journal-title":"Transplantation"},{"key":"10.1016\/j.transci.2016.01.008_bib0045","author":"Pasquini"},{"issue":"8","key":"10.1016\/j.transci.2016.01.008_bib0050","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.bbmt.2013.03.018","article-title":"Clinical guide to ABO-incompatible allogeneic stem cell transplantation","volume":"19","author":"Booth","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.transci.2016.01.008_bib0055","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/sj.bmt.1704579","article-title":"ABO-incompatible bone marrow transplantation: a GITMO survey of current practice in Italy and comparison with the literature","volume":"34","author":"Raimondi","year":"2004","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"10.1016\/j.transci.2016.01.008_bib0060","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1309\/VXY1ULAFUY6E6JT3","article-title":"Clinical outcomes of ABO-incompatible RBC transfusions","volume":"129","author":"Janapour","year":"2008","journal-title":"Am J Clin Pathol"},{"issue":"4","key":"10.1016\/j.transci.2016.01.008_bib0065","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/sj.bmt.1703135","article-title":"Hematopoietic stem cell transplantation between red cell incompatible donor-recipient pairs","volume":"28","author":"Rowley","year":"2001","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"10.1016\/j.transci.2016.01.008_bib0070","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1177\/107327481502200108","article-title":"Transfusion support issues in hematopoietic stem cell transplantation","volume":"22","author":"Cohn","year":"2015","journal-title":"Cancer Control"},{"issue":"6","key":"10.1016\/j.transci.2016.01.008_bib0075","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1097\/MOH.0b013e3282e9a576","article-title":"Immune hemolysis following ABO-mismatched stem cell or solid organ transplantation","volume":"14","author":"Yazer","year":"2007","journal-title":"Curr Opin Hematol"},{"issue":"6","key":"10.1016\/j.transci.2016.01.008_bib0080","first-page":"793","article-title":"Erythrocyte repopulation after major ABO incompatible transplantation with lymphocyte-depleted bone marrow","volume":"16","author":"B\u00e4r","year":"1995","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"10.1016\/j.transci.2016.01.008_bib0085","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S1083-8791(98)50004-3","article-title":"Prolonged erythroid aplasia after major ABO-mismatched transplantation for chronic myelogenous leukemia","volume":"4","author":"Benjamin","year":"1998","journal-title":"Biol Blood Marrow Transplant"},{"issue":"6","key":"10.1016\/j.transci.2016.01.008_bib0090","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1182\/blood.V98.6.1687","article-title":"Delayed donor red cell chimerism and pure red cell aplasia following major ABO-incompatible nonmyeloablative hematopoietic stem cell transplantation","volume":"98","author":"Bolan","year":"2001","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.transci.2016.01.008_bib0095","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1053\/j.seminhematol.2005.05.017","article-title":"Immune hemolysis associated with transplantation","volume":"42","author":"Petz","year":"2005","journal-title":"Semin Hematol"},{"issue":"3","key":"10.1016\/j.transci.2016.01.008_bib0100","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1046\/j.1365-2141.2001.02587.x","article-title":"Massive immune haemolysis after allogeneic peripheral blood stem cell transplantation with minor ABO incompatibility","volume":"112","author":"Bolan","year":"2001","journal-title":"Br J Haematol"},{"issue":"6","key":"10.1016\/j.transci.2016.01.008_bib0105","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1046\/j.1365-3148.2001.00334.x","article-title":"Massive haemolysis in a group A recipient of a group O peripheral blood stem cell allogeneic transplant","volume":"11","author":"Tiplady","year":"2001","journal-title":"Transfus Med"},{"issue":"10","key":"10.1016\/j.transci.2016.01.008_bib0110","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1046\/j.1537-2995.2002.00209.x","article-title":"Severe immune hemolysis after minor ABO-mismatched allogeneic peripheral blood progenitor cell transplantation occurs more frequently after nonmyeloablative than myeloablative conditioning","volume":"42","author":"Worel","year":"2002","journal-title":"Transfusion"},{"issue":"1","key":"10.1016\/j.transci.2016.01.008_bib0115","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1046\/j.1537-2995.1996.36196190519.x","article-title":"Exchange transfusion the hard way: massive hemolysis following transplantation of bone marrow with minor ABO incompatibility","volume":"36","author":"Greeno","year":"1996","journal-title":"Transfusion"},{"issue":"3\u20134","key":"10.1016\/j.transci.2016.01.008_bib0120","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.trim.2005.03.005","article-title":"Is the ABO incompatibility a risk factor in bone marrow transplantation?","volume":"14","author":"Rozman","year":"2005","journal-title":"Transpl Immunol"},{"issue":"5","key":"10.1016\/j.transci.2016.01.008_bib0125","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/sj.bmt.1704816","article-title":"Impact of ABO incompatibility on outcome after allogeneic peripheral blood stem cell transplantation","volume":"35","author":"Kim","year":"2005","journal-title":"Bone Marrow Transplant"},{"issue":"9","key":"10.1016\/j.transci.2016.01.008_bib0130","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/sj.bmt.1705496","article-title":"Lack of effect of donor-recipient ABO mismatching on outcome following allogeneic hematopoietic stem cell transplantation","volume":"38","author":"Klumpp","year":"2006","journal-title":"Bone Marrow Transplant"},{"issue":"9","key":"10.1016\/j.transci.2016.01.008_bib0135","doi-asserted-by":"crossref","first-page":"3851","DOI":"10.1016\/j.transproceed.2009.06.189","article-title":"Impact of ABO-incompatible donor on early and late outcome of hematopoietic stem cell transplantation","volume":"41","author":"Ozkurt","year":"2009","journal-title":"Transplant Proc"},{"issue":"8","key":"10.1016\/j.transci.2016.01.008_bib0140","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1046\/j.1537-2995.2003.00465.x","article-title":"ABO mismatch increases transplant-related morbidity and mortality in patients given nonmyeloablative allogeneic HPC transplantation","volume":"43","author":"Worel","year":"2003","journal-title":"Transfusion"},{"issue":"2","key":"10.1016\/j.transci.2016.01.008_bib0145","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1046\/j.1537-2995.1999.39299154733.x","article-title":"ABO incompatibility as an adverse risk factor for survival after allogeneic bone marrow transplantation","volume":"39","author":"Benjamin","year":"1999","journal-title":"Transfusion"},{"issue":"12","key":"10.1016\/j.transci.2016.01.008_bib0150","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.bbmt.2005.07.015","article-title":"GVHD Working Committee of Center for International Blood and Marrow Transplant Research. ABO blood group barrier in allogeneic bone marrow transplantation revisited","volume":"11","author":"Seebach","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"issue":"9","key":"10.1016\/j.transci.2016.01.008_bib0155","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/j.bbmt.2010.03.021","article-title":"Impact of donor-recipient major ABO mismatch on allogeneic transplantation outcome according to stem cell source","volume":"16","author":"Blin","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"10.1016\/j.transci.2016.01.008_bib0160","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/pbc.21025","article-title":"ABO incompatible stem cell transplantation in children does not influence outcome","volume":"49","author":"Helming","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.transci.2016.01.008_bib0165","doi-asserted-by":"crossref","DOI":"10.1111\/petr.12552","article-title":"Is ABO mismatch another risk factor for allogeneic hematopoietic stem cell transplantation in pediatric thalassemic patients?","author":"Atay","year":"2015","journal-title":"Pediatr Transplant"},{"issue":"6","key":"10.1016\/j.transci.2016.01.008_bib0170","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.bbmt.2007.01.084","article-title":"Major ABO blood group mismatch increases the risk for graft failure after unrelated donor hematopoietic stem cell transplantation","volume":"13","author":"Remberger","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"10.1016\/j.transci.2016.01.008_bib0175","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/sj.bmt.1702121","article-title":"Anti-A isoaglutinin as a risk factor for the development of pure red cell aplasia after major ABO-incompatible allogeneic bone marrow transplantation","volume":"25","author":"Lee","year":"2000","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"10.1016\/j.transci.2016.01.008_bib0180","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1159\/000205063","article-title":"Pure red-cell aplasia of long duration after major ABO-incompatible bone marrow transplantation","volume":"84","author":"Volin","year":"1990","journal-title":"Acta Haematol"},{"issue":"3","key":"10.1016\/j.transci.2016.01.008_bib0185","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/j.1537-2995.2009.02461.x","article-title":"Prolonged isolated red blood cell transfusion requirement after allogeneic blood stem cell transplantation: identification of patients at risk","volume":"50","author":"Dahl","year":"2010","journal-title":"Transfusion"},{"issue":"2","key":"10.1016\/j.transci.2016.01.008_bib0190","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1365-2141.1984.tb06085.x","article-title":"A ve B blood group antigen expression on mixed colony cells and erythroid precursors: relevance for human allogeneic bone marrow transplantation","volume":"58","author":"Blaclock","year":"1984","journal-title":"Br J Haematol"},{"issue":"12","key":"10.1016\/j.transci.2016.01.008_bib0195","doi-asserted-by":"crossref","first-page":"4425","DOI":"10.1182\/blood.V93.12.4425","article-title":"The expression of human blood group antigens during erythropoiesis in a cell culture system","volume":"93","author":"Southcott","year":"1999","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.transci.2016.01.008_bib0200","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.bbmt.2013.04.004","article-title":"PRCA Collaborative Study Group. Efficacy and long-term outcome of treatment for pure red cell aplasia after allogeneic stem cell transplantation from major ABO-incompatible donors","volume":"19","author":"Hirokawa","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"issue":"6","key":"10.1016\/j.transci.2016.01.008_bib0205","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/sj.bmt.1703668","article-title":"Successful treatment of pure red cell aplasia with a single dose of rituximab in a child after major ABO incompatible peripheral blood allogeneic stem cell transplantation for acquired aplastic anemia","volume":"30","author":"Maschan","year":"2002","journal-title":"Bone Marrow Transplant"},{"issue":"Suppl. ECR33","key":"10.1016\/j.transci.2016.01.008_bib0210","article-title":"Successful treatment of pure red cell aplasia with repeated, low dose of rituximab in two patients after ABO-incompatible allogeneic haematopoietic stem cell transplantation for acute myeloid leukaemia","volume":"90","author":"Helbig","year":"2005","journal-title":"Haematologica"},{"issue":"6","key":"10.1016\/j.transci.2016.01.008_bib0215","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1600-0609.2004.00320.x","article-title":"Resistant pure red cell aplasia after allogeneic stem cell transplantation with major ABO mismatch treated by escalating dose donor leukocyte infusion","volume":"73","author":"Verholen","year":"2004","journal-title":"Eur J Haematol"},{"issue":"5","key":"10.1016\/j.transci.2016.01.008_bib0220","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1007\/BF02984003","article-title":"The effect of donor leukocyte infusion on refractory pure red blood cell aplasia after allogeneic stem cell transplantation in a patient with myelodysplastic syndrome developing from Kostmann syndrome","volume":"86","author":"Ebihara","year":"2007","journal-title":"Int J Hematol"},{"issue":"5","key":"10.1016\/j.transci.2016.01.008_bib0225","first-page":"471","article-title":"Antilymphocyte globulin for treatment of pure red cell aplasia after major ABO incompatible marrow transplant","volume":"10","author":"Labar","year":"1992","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"10.1016\/j.transci.2016.01.008_bib0230","first-page":"471","article-title":"Pure red cell aplasia complicating an ABO-compatible allogeneic bone marrow transplantation, treated successfully with antithymocyte globulin","volume":"16","author":"Roychowdhury","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.transci.2016.01.008_bib0235","doi-asserted-by":"crossref","DOI":"10.1111\/tme.12216","article-title":"Successful treatment of refractory pure red cell aplasia with bortezomib after allogeneic haematopoietic cell transplantation in a patient with alpha-beta subcutaneous panniculitis-like T cell lymphoma","author":"Shahan","year":"2015","journal-title":"Transfus Med"},{"issue":"2","key":"10.1016\/j.transci.2016.01.008_bib0240","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3324\/haematol.13356","article-title":"Prevention of pure red cell aplasia after major or bidirectional ABO blood group incompatible hematopoietic stem cell transplantation by pretransplant reduction of host anti-donor isoagglutinins","volume":"94","author":"Stussi","year":"2009","journal-title":"Haematologica"},{"issue":"5","key":"10.1016\/j.transci.2016.01.008_bib0245","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.exphem.2008.01.017","article-title":"Predictive factors for outcomes after reduced intensity conditioning hematopoietic stem cell transplantation for hematological malignancies: a 10-year retrospective analysis from the Soci\u00e9t\u00e9 Fran\u00e7aise de Greffe de Moelle et de Th\u00e9rapie Cellulaire","volume":"36","author":"Michallet","year":"2008","journal-title":"Exp Hematol"},{"issue":"1","key":"10.1016\/j.transci.2016.01.008_bib0250","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1365-2141.2009.08073.x","article-title":"The impact of donor type and ABO incompatibility on transfusion requirements after nonmyeloablative haematopoietic cell transplantation","volume":"149","author":"Wang","year":"2010","journal-title":"Br J Haematol"},{"issue":"2","key":"10.1016\/j.transci.2016.01.008_bib0255","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/sj.bmt.1703621","article-title":"Consequences of ABO incompatibility in allogeneic hematopoietic stem cell transplantation","volume":"30","author":"Stussi","year":"2002","journal-title":"Bone Marrow Transplant"},{"issue":"7","key":"10.1016\/j.transci.2016.01.008_bib0260","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1182\/blood.V98.7.2043","article-title":"Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age","volume":"98","author":"Kollman","year":"2001","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.transci.2016.01.008_bib0265","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.bbmt.2008.01.003","article-title":"ABO incompatibility is associated with increased non-relapse and GVHD related mortality in patients with malignancies treated with a reduced intensity regimen: a single center experience of 221 patients","volume":"14","author":"Resnick","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"issue":"9","key":"10.1016\/j.transci.2016.01.008_bib0270","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1038\/bmt.2011.135","article-title":"Red blood cell-incompatible allogeneic hematopoietic progenitor cell transplantation","volume":"46","author":"Rowley","year":"2011","journal-title":"Bone Marrow Transplant"},{"issue":"Suppl. 1","key":"10.1016\/j.transci.2016.01.008_bib0275","first-page":"7","article-title":"A technique for isolation of bone marrow cells using hydroxyethyl starch (HES) sedimentation agent","volume":"76","author":"Montuoro","year":"1991","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/j.transci.2016.01.008_bib0280","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1046\/j.1537-2995.1982.22382224944.x","article-title":"Comparison of two methods for concentrating stem cells for cryopreservation and transplantation","volume":"22","author":"Ma","year":"1982","journal-title":"Transfusion"},{"issue":"3","key":"10.1016\/j.transci.2016.01.008_bib0285","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/j.1537-2995.2006.00735.x","article-title":"ABO-mismatched marrow processing for transplantation: results of 114 procedures and analysis of immediate adverse events and hematopoietic recovery","volume":"46","author":"Larghero","year":"2006","journal-title":"Transfusion"},{"issue":"4","key":"10.1016\/j.transci.2016.01.008_bib0290","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/jca.20293","article-title":"Bone marrow processing with the AMICUS\u2122 separator system","volume":"26","author":"Witt","year":"2011","journal-title":"J Clin Apher"},{"issue":"8","key":"10.1016\/j.transci.2016.01.008_bib0295","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1111\/j.1537-2995.2007.01289.x","article-title":"Prophylactic red blood cell exchange for prevention of severe immune hemolysis in minor ABO-mismatched allogeneic peripheral blood progenitor cell transplantation after reduced-intensity conditioning","volume":"47","author":"Worel","year":"2007","journal-title":"Transfusion"},{"issue":"1","key":"10.1016\/j.transci.2016.01.008_bib0300","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.transci.2009.10.013","article-title":"ABO-mismatched platelet transfusions: strategies to mitigate patient exposure to naturally occurring hemolytic antibodies","volume":"42","author":"Josephson","year":"2010","journal-title":"Transfus Apher Sci"},{"issue":"1","key":"10.1016\/j.transci.2016.01.008_bib0305","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/bmt.2008.79","article-title":"Rituximab for passenger lymphocyte syndrome associated with allogeneic SCT","volume":"42","author":"Lee","year":"2008","journal-title":"Bone Marrow Transplant"}],"container-title":["Transfusion and Apheresis Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050216000100?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050216000100?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,13]],"date-time":"2020-09-13T20:52:57Z","timestamp":1600030377000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1473050216000100"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["S1473050216000100"],"URL":"https:\/\/doi.org\/10.1016\/j.transci.2016.01.008","relation":{},"ISSN":["1473-0502"],"issn-type":[{"value":"1473-0502","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ABO blood group mismatched hematopoietic stem cell transplantation","name":"articletitle","label":"Article Title"},{"value":"Transfusion and Apheresis Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transci.2016.01.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}